Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Net Income: 2019-2025

Historic Net Income for Nurix Therapeutics (NRIX) over the last 6 years, with Aug 2025 value amounting to -$86.4 million.

  • Nurix Therapeutics' Net Income fell 76.53% to -$86.4 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$244.8 million, marking a year-over-year decrease of 38.32%. This contributed to the annual value of -$193.6 million for FY2024, which is 34.47% down from last year.
  • According to the latest figures from Q3 2025, Nurix Therapeutics' Net Income is -$86.4 million, which was down 98.83% from -$43.5 million recorded in Q2 2025.
  • Over the past 5 years, Nurix Therapeutics' Net Income peaked at -$24.3 million during Q1 2021, and registered a low of -$86.4 million during Q3 2025.
  • Its 3-year average for Net Income is -$47.6 million, with a median of -$43.5 million in 2025.
  • Per our database at Business Quant, Nurix Therapeutics' Net Income slumped by 448.05% in 2021 and then skyrocketed by 46.53% in 2023.
  • Nurix Therapeutics' Net Income (Quarterly) stood at -$37.7 million in 2021, then dropped by 23.95% to -$46.7 million in 2022, then climbed by 10.19% to -$42.0 million in 2023, then tumbled by 39.55% to -$58.5 million in 2024, then crashed by 76.53% to -$86.4 million in 2025.
  • Its last three reported values are -$86.4 million in Q3 2025, -$43.5 million for Q2 2025, and -$56.4 million during Q1 2025.